Skip to content
healthcare.dev
Get a free key

Xofluza

NDC 50242-599, Baloxavir Marboxil, granule, for suspension, from Genentech, Inc..

Product NDC
50242-599
Status
Listed
Labeler
Genentech, Inc.
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214410
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-599 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BALOXAVIR MARBOXIL30 mg/1

Pharmacologic classes

Chelating Activity [MoA]; Polymerase Acidic Endonuclease Inhibitor [EPC]; Polymerase Acidic Endonuclease Inhibitors [MoA]

Package NDCNDC-11Package
50242-599-01502420599011 PACKET in 1 CARTON (50242-599-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e49e1a61-1b7c-4be5-ac84-af6240b511e7

Use it

Look up 50242-599 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-599 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-599. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.